Colorectal cancer (CRC) is one of the most common malignancies worldwide. China,
Europe and northern America account for more than half of the new CRC cases and …

Cancer screening has the potential to decrease mortality from several common cancer
types. The first cancer screening programme in China was initiated in 1958 and the Cancer …

Objective Colorectal cancer (CRC) is the third most common cancer worldwide. The
geographical and temporal burden of this cancer provides insights into risk factor …

Abstract Background N‐acetyltransferase 10 (NAT10) is the only enzyme known to mediate
the N4‐acetylcytidine (ac4C) modification of mRNA and is crucial for mRNA stability and …

This article presents global cancer statistics by world region for the year 2022 based on
updated estimates from the International Agency for Research on Cancer (IARC). There …

Colorectal cancer (CRC) incidence rates decreased by up to 50% in older age groups in the
USA in the era of the widespread uptake of screening colonoscopy, despite adverse trends …

Background An increasing proportion of colorectal cancers (CRCs) are detected through
screening due to the availability of organised population-based programmes. We aimed to …

Importance Although treatment and prognosis of synchronous liver metastases from
colorectal cancer are relatively well known, a comparative description of the incidence …

Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), an RNA-binding protein, is
associated with tumorigenesis and progression. However, the exact molecular mechanisms …

Colorectal cancer (CRC) is the second most common cause of cancer incidence worldwide.
Oral drug delivery systems (ODDS) have shown great promise for CRC therapy, but the …